News & Updates

Show Multimedia Only
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta

Bulevirtide boasts high barrier to resistance for chronic hepatitis delta

13 Sep 2023
Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia

Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia

08 Sep 2023 byAudrey Abella

In patients admitted to the intensive care unit (ICU) for severe community-acquired pneumonia (CAP), those who received hydrocortisone had a lower mortality risk compared with those on placebo, findings from the CAPE COD* trial suggest.

Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia

08 Sep 2023